|
LIVING CELL TECHNOLOGIES LIMITED ASX: LCT - Living Cell Technologies Granted Diabetes Patent in the US - Mr David Collinson, CEO & Executive Director
Sydney, July 7, 2006 (ABN Newswire) - LIVING CELL TECHNOLOGIES LIMITED (ASX: LCT) - Living Cell Technologies Granted Diabetes Patent in the US - Mr David Collinson, CEO & Executive Director; Boardroomradio is pleased to announce that LIVING CELL TECHNOLOGIES LIMITED (ASX: LCT) has published an audio file. The following presentation "Living Cell Technologies Granted Diabetes Patent in the US" is now available as an instant audio download to your computer. You may also transfer this information to your listening device as an IPod podcast. The BRR service is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider. Broadcaster: LIVING CELL TECHNOLOGIES LIMITED (ASX: LCT) Broadcast Title: Living Cell Technologies Granted Diabetes Patent in the US Broadcast Type: Audio stream View the Audio stream for LIVING CELL TECHNOLOGIES LIMITED (ASX: LCT) by clicking on the following links. Display in Windows Media Player http://www.boardroomradio.com/event/LCT/1278/12375/wmp/221.242.254.150/wsl.wmp? or: Display in MP3 Player or Transfer to Portable Podcast Device http://www.boardroomradio.com/event/LCT/1278/12375/mp3/221.242.254.150/wsl.mp3? Computers set up for access to the Internet, including at least a 28.8k modem and sufficient memory and hard disk space to run Windows Media Player or Real Player, should be able to run BRR media files.
About LIVING CELL TECHNOLOGIES LIMITED
Living Cell Technologies Ltd (LCT) is an advanced biotechnology company currently listed on the Australian Stock Exchange. LCT’s focus is on market-driven encapsulated living cell products, for the treatment of Huntington's disease, haemophilia and insulin-dependent diabetes. LCT’s business was formed in 1987 to research cell extraction and to develop procedures for advanced living-cell replacement therapies.
About Boardroomradio
Sydney-based Boardroomradio (BRR) is an Investor Relations multi-media portal delivering audio webcasts to the investment community, including brokers, fund managers, analysts, and private investors.
|
|
2007/10/22 17:31
Aust Market Wrap, (ASX: LCT), (ASX: QAN), (ASX: MBL), (ASX: GFF), (ASX: SHG), (ASX: NCK), (ASX: ALL)
| 2007/10/09 13:11
Aust Market At Midday, (ASX: CIF), (ASX: LCT), (NYSE: JPM)
| 2007/09/12 17:22
Aust Market Wrap, (ASX: WES), (ASX: CGJ), (ASX: TLS), (ASX: CNP), (ASX: CSH), (ASX: SMY), (ASX: LCT)
| | | |
|
|